84 related articles for article (PubMed ID: 1655225)
1. In vitro uptake of bromodeoxyuridine by human hepatocellular carcinoma and its relation to histopathologic findings and biologic behavior.
Tarao K; Shimizu A; Harada M; Ohkawa S; Okamoto N; Kuni Y; Ito Y; Tamai S; Iimori K; Sugimasa I
Cancer; 1991 Oct; 68(8):1789-94. PubMed ID: 1655225
[TBL] [Abstract][Full Text] [Related]
2. DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC.
Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Okamoto N; Ito Y; Tamai S; Iimori K; Sugimasa Y
Cancer; 1993 Jun; 71(12):3859-63. PubMed ID: 8389652
[TBL] [Abstract][Full Text] [Related]
3. Difference in the in vitro uptake of bromodeoxyuridine between liver cirrhosis with and without hepatocellular carcinoma.
Tarao K; Shimizu A; Harada M; Kuni Y; Ito Y; Tamai S; Iimori K; Sugimasa Y; Takemiya S; Okamoto T
Cancer; 1989 Jul; 64(1):104-9. PubMed ID: 2543491
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
5. Evidence of sex difference in DNA synthesis in hepatocellular carcinoma.
Tarao K; Shimizu A; Harada M; Ono T; Kuni Y; Ohkawa S; Ito Y; Tamai S; Iimori K; Sugimasa Y
Jpn J Cancer Res; 1991 Aug; 82(8):922-6. PubMed ID: 1654312
[TBL] [Abstract][Full Text] [Related]
6. [Biological activity of hepatocellular carcinoma by analysing nuclear DNA ploidy patterns and using anti BrdU monoclonal antibody].
Jung-Rou T
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):168-80. PubMed ID: 2546033
[TBL] [Abstract][Full Text] [Related]
7. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma.
Tarao K; Hoshino H; Shimizu A; Ohkawa S; Nakamura Y; Harada M; Ito Y; Tamai S; Akaike M; Sugimasa Y
Jpn J Cancer Res; 1994 Oct; 85(10):1040-4. PubMed ID: 7961106
[TBL] [Abstract][Full Text] [Related]
8. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.
Zhou Q; He Q; Liang LJ
World J Gastroenterol; 2003 Nov; 9(11):2450-4. PubMed ID: 14606074
[TBL] [Abstract][Full Text] [Related]
9. S-phase cells in diseased human liver determined by an in vitro BrdU-anti-BrdU method.
Shimizu A; Tarao K; Takemiya S; Harada M; Inoue T; Ono T
Hepatology; 1988; 8(6):1535-9. PubMed ID: 2847968
[TBL] [Abstract][Full Text] [Related]
10. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?
Shirabe K; Matsumata T; Adachi E; Maeda T; Shimada M; Taketomi A; Sugimachi K
Hepatogastroenterology; 1995; 42(6):923-30. PubMed ID: 8847047
[TBL] [Abstract][Full Text] [Related]
12. Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity.
Ikeguchi M; Sato N; Hirooka Y; Kaibara N
J Surg Oncol; 1998 Aug; 68(4):225-30. PubMed ID: 9721707
[TBL] [Abstract][Full Text] [Related]
13. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma.
Zeng WJ; Liu GY; Xu J; Zhou XD; Zhang YE; Zhang N
World J Gastroenterol; 2002 Dec; 8(6):1040-4. PubMed ID: 12439921
[TBL] [Abstract][Full Text] [Related]
14. The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men.
Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Ito Y; Tamai S; Hoshino H; Okamoto N; Iimori K
Cancer; 1993 Jul; 72(2):369-74. PubMed ID: 7686441
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
17. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.
Liu YB; Gao SL; Chen XP; Peng SY; Fang HQ; Wu YL; Peng CH; Tang Z; Xu B; Wang JW; Deng GL; Li HJ; Feng XD; Qian HR
World J Gastroenterol; 2005 Mar; 11(9):1378-81. PubMed ID: 15761980
[TBL] [Abstract][Full Text] [Related]
19. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
[TBL] [Abstract][Full Text] [Related]
20. Cellular DNA content and histopathological analysis in hepatocellular carcinoma with multiple nodules.
Ichikawa N; Fujimoto J; Okamoto E; Yamanaka N; Nishigami T
Surg Today; 1997; 27(6):483-90. PubMed ID: 9306539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
